Characterization of ATI, TK and IFN-alpha/betaR genes in the genome of the BeAn 58058 virus, a naturally attenuated wild Orthopoxvirus.
The lack of knowledge about the natural host of Vaccinia virus (VV) along with the description of human infections caused by poxviruses after smallpox eradication has increased the need to characterize poxviruses isolated from the wild. Moreover, in the past years poxviruses have been widely studied as potential vaccination tools, with the discovery of several genes implicated in the evasion of the host immune response involved in virus pathogenesis. Among them, an Interferon (IFN)-binding protein was identified in the supernatant of VV strain WR infected cells coded by the B18R gene. It was shown that many other Orthopoxviruses also encode and express this soluble receptor although some VV strains such as Lister and modified Ankara, which were less reactogenic vaccines, do not. The BeAn 58058 virus (BAV) has been recently characterized and proposed to be an Orthopoxvirus. BAV was also shown to be less virulent in animal models than VV Lister. Here we report the identification of an IFN-alpha/betaR gene in the BAV genome with 99% of sequence identity with the VVWR B18R gene. The identified gene encodes a B18R-like IFN binding protein as demonstrated by its capacity to inhibit the IFN-mediated protection of VERO cells against EMC virus. In order to better characterize the virus we have searched for the A type inclusion body (ATI) gene currently used in the classification of Orthopoxviruses but did not detect it in the BAV genome. We have also sequenced the BAV thymidine kinase (TK) gene, a poxvirus-conserved gene, which, as expected, showed high homology with the TK gene of other poxviruses. Phylogenetic trees were constructed based on sequences of the IFN-alpha/betaR and TK genes from several poxviruses and in both cases BAV was placed in the same cluster as other VV strains. These observations strengthened the hypothesis that this virus is a variant of the VV vaccine used in Brazil. However the explanation for the BAV lack of virulence remains to be discovered.
Marques
J T
JT
Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
Trindade
G D
GD
Da Fonseca
F G
FG
Dos Santos
J R
JR
Bonjardim
C A
CA
Ferreira
P C
PC
Kroon
E G
EG
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D001483:Base Sequence; D002522:Chlorocebus aethiops; D004279:DNA, Viral; D016679:Genome, Viral; D007181:Inclusion Bodies, Viral / Q000235:genetics; D007372:Interferons / Q000037:antagonists & inhibitors; D008565:Membrane Proteins; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D018155:Orthopoxvirus / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D053633:Receptor, Interferon alpha-beta; D017471:Receptors, Interferon / Q000737:chemistry / Q000235:genetics*; D017422:Sequence Analysis, DNA; D012689:Sequence Homology, Nucleic Acid; D013937:Thymidine Kinase / Q000235:genetics*; D014709:Vero Cells; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics*
D000914:Antibodies, Viral; D004279:DNA, Viral; D008565:Membrane Proteins; D017471:Receptors, Interferon; D014764:Viral Proteins; C067853:B18R protein, Vaccinia virus; D053633:Receptor, Interferon alpha-beta; D007372:Interferons; D013937:Thymidine Kinase